These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12467233)

  • 1. Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines.
    He L; Yang CP; Horwitz SB
    Mol Cancer Ther; 2001 Nov; 1(1):3-10. PubMed ID: 12467233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence.
    Yang CP; Verdier-Pinard P; Wang F; Lippaine-Horvath E; He L; Li D; Höfle G; Ojima I; Orr GA; Horwitz SB
    Mol Cancer Ther; 2005 Jun; 4(6):987-95. PubMed ID: 15956256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to microtubule-stabilizing drugs involves two events: beta-tubulin mutation in one allele followed by loss of the second allele.
    Wang Y; O'Brate A; Zhou W; Giannakakou P
    Cell Cycle; 2005 Dec; 4(12):1847-53. PubMed ID: 16294009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation.
    Martello LA; Verdier-Pinard P; Shen HJ; He L; Torres K; Orr GA; Horwitz SB
    Cancer Res; 2003 Mar; 63(6):1207-13. PubMed ID: 12649178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions.
    Verrills NM; Flemming CL; Liu M; Ivery MT; Cobon GS; Norris MD; Haber M; Kavallaris M
    Chem Biol; 2003 Jul; 10(7):597-607. PubMed ID: 12890533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
    Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.
    Kanakkanthara A; Rowe MR; Field JJ; Northcote PT; Teesdale-Spittle PH; Miller JH
    Cancer Lett; 2015 Sep; 365(2):251-60. PubMed ID: 26052091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and development of the epothilones : a novel class of antineoplastic drugs.
    Reichenbach H; Höfle G
    Drugs R D; 2008; 9(1):1-10. PubMed ID: 18095749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
    Hari M; Loganzo F; Annable T; Tan X; Musto S; Morilla DB; Nettles JH; Snyder JP; Greenberger LM
    Mol Cancer Ther; 2006 Feb; 5(2):270-8. PubMed ID: 16505100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for drug resistance conferred by β-tubulin mutations: a molecular modeling study on native and mutated tubulin complexes with epothilone B.
    Navarrete KR; Alderete JB; Jiménez VA
    J Biomol Struct Dyn; 2015; 33(12):2530-40. PubMed ID: 26081685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents.
    Liberatore AM; Coulomb H; Pons D; Dutruel O; Kasprzyk PG; Carlson M; Nelson AS; Newman SP; Stengel C; Auvray P; Hesry V; Foll B; Narboux N; Morlais D; Le Moing M; Bernetiere S; Dellile R; Camara J; Ferrandis E; Bigg DC; Prévost GP
    Mol Cancer Ther; 2008 Aug; 7(8):2426-34. PubMed ID: 18723488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology and medicinal chemistry of epothilones.
    Wartmann M; Altmann KH
    Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):123-48. PubMed ID: 12678754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomolar concentrations of epothilone D inhibit the proliferation of glioma cells and severely affect their tubulin cytoskeleton.
    Dietzmann A; Kanakis D; Kirches E; Kropf S; Mawrin C; Dietzmann K
    J Neurooncol; 2003 Nov; 65(2):99-106. PubMed ID: 14686728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.
    Loganzo F; Hari M; Annable T; Tan X; Morilla DB; Musto S; Zask A; Kaplan J; Minnick AA; May MK; Ayral-Kaloustian S; Poruchynsky MS; Fojo T; Greenberger LM
    Mol Cancer Ther; 2004 Oct; 3(10):1319-27. PubMed ID: 15486199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
    Gertsch J; Meier S; Müller M; Altmann KH
    Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)).
    Kowalski RJ; Giannakakou P; Hamel E
    J Biol Chem; 1997 Jan; 272(4):2534-41. PubMed ID: 8999970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.
    Wiesen KM; Xia S; Yang CP; Horwitz SB
    Cancer Lett; 2007 Nov; 257(2):227-35. PubMed ID: 17869412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.
    Escuin D; Kline ER; Giannakakou P
    Cancer Res; 2005 Oct; 65(19):9021-8. PubMed ID: 16204076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry.
    Verdier-Pinard P; Wang F; Martello L; Burd B; Orr GA; Horwitz SB
    Biochemistry; 2003 May; 42(18):5349-57. PubMed ID: 12731876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.